Product Introduction

Oncolytic viruses (OVs) are a class of conditionally replicative viral particles that can selectively replicate within tumor cells and kill them without harming normal cells. While destroying tumor cells, OVs can also stimulate the body to produce anti-tumor immunity. Recombinant oncolytic viruses can effectively achieve tumor targeting and overcome the tumor microenvironment, activating anti-tumor immunity and transforming "cold" tumors into "hot" tumors, thereby enhancing the efficacy of cancer treatment.

Product Advantages

1.Modular viral vector preparation technology platform

Based on the modular recombinant virus preparation platform, arbitrary modification of viruses is basically achieved, shortening the virus preparation cycle to 1/4 to 1/6 of the original cycle.

2. Rich database of virus products

We can provide oncolytic adenovirus, VSV, HSV and other oncolytic virus vectors.

3. Strict quality control

10 process quality control items and 6 quality inspection items.

Application Case